FIELD: medicine.
SUBSTANCE: invention relates to use of NADP-oxidase inhibitors. Application of NADP-oxidase inhibitors as medicinal agent for normalization of female reproductive system cell metabolism in treatment of endometriosis.
EFFECT: use of the invention provides higher therapeutic effectiveness and reduced probability of recurrences due to normalization of metabolism of pathological cells involved in the development of endometriosis.
1 cl, 7 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
DRUG FOR TREATING ENDOMETRIOSIS | 2024 |
|
RU2839308C1 |
METHOD FOR PROTECTING NEURONS IN NEURODEGENERATIVE DISEASES AND APPARATUS FOR IMPLEMENTATION THEREOF | 2021 |
|
RU2783111C1 |
METHOD FOR CREATING CELL MODEL OF PREMATURE OVARIAN FAILURE IN WISTAR RATS | 2023 |
|
RU2815539C1 |
METHOD FOR CREATING CELL MODEL OF DRUG EXPOSURE ON PATHOGENESIS OF PREMATURE OVARIAN FAILURE IN RATS | 2024 |
|
RU2837330C1 |
DEVICE FOR FLUORESCENT-REFLECTIVE SPECTROSCOPY FOR DIAGNOSING FOCAL AND DIFFUSE NEW GROWTHS IN A FINE-NEEDLE PUNCTURE-ASPIRATION BIOPSY | 2018 |
|
RU2709830C1 |
METHOD FOR PREDICTION OF PREGNANCY RATE THROUGH IN VITRO FERTILISATION WITH SELECTIVE EMBRYO TRANSFER BY REAL-TIME PCR EVALUATION OF MOLECULAR GENETIC GAMETE PROFILE | 2014 |
|
RU2550965C1 |
DEVICE FOR OPTICAL DIAGNOSTICS OF BLOOD SUPPLY AND LIFE SUPPORT OF BIO-TISSUES | 2017 |
|
RU2663938C1 |
METHOD OF INCREASING THE EFFICIENCY OF PROTON THERAPY ON MELANOMA STEM CELLS | 2022 |
|
RU2798733C2 |
AMIDE OF NONAPEPTIDE PREVENTING INCREASE OF HYPERPERMEABILITY OF VESSEL ENDOTHELIUM | 2012 |
|
RU2493164C1 |
USE OF 5'-O-(3-PHENYLPROPIONYL)-N4-HYDROXYCYTIDINE TO INHIBIT INFLUENZA VIRUS REPLICATION IN VITRO AND IN VIVO | 2022 |
|
RU2791806C1 |
Authors
Dates
2024-05-06—Published
2022-12-13—Filed